Abcellera Biologics Inc (ABCL) — Financial Flexibility Index
Abcellera Biologics Inc (ABCL) has a Financial Flexibility Index of -0.12x as of December 2025. Free cash flow of $-24.90 Million (operating CF $-34.74 Million minus capex $9.84 Million) represents 0% of total liabilities ($215.59 Million). Also explore Abcellera Biologics Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Abcellera Biologics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Abcellera Biologics Inc across 8 annual periods. Check asset allocation strategy of Abcellera Biologics Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Abcellera Biologics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Abcellera Biologics Inc. For the full company profile including market capitalisation, see how much is Abcellera Biologics Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.41x | $-88.52 Million | $-131.29 Million | $215.59 Million | ▼ -314.5% |
| 2024 | -0.10x | $-30.16 Million | $-108.56 Million | $304.47 Million | ▼ -198.9% |
| 2023 | 0.10x | $33.63 Million | $-43.88 Million | $335.78 Million | ▼ -91.2% |
| 2022 | 1.14x | $350.02 Million | $277.36 Million | $307.63 Million | ▲ +9.9% |
| 2021 | 1.03x | $303.04 Million | $244.58 Million | $292.84 Million | ▲ +384.8% |
| 2020 | 0.21x | $37.36 Million | $22.69 Million | $175.03 Million | ▼ -57.8% |
| 2019 | 0.51x | $6.69 Million | $2.69 Million | $13.24 Million | ▼ -43.7% |
| 2018 | 0.90x | $8.87 Million | $3.56 Million | $9.88 Million | — |